Survivin as a global target of intrinsic tumor suppression networks

被引:125
作者
Guha, Minakshi [1 ]
Altieri, Dario C. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA
关键词
survivin; PTEN; tumor suppressor; apoptosis; gene regulation; WILD-TYPE P53; ANTITUMOR-ACTIVITY; GENE-EXPRESSION; BREAST-CANCER; APOPTOSIS; PATHWAY; REPRESSION; INHIBITOR; THERAPY; MITOSIS;
D O I
10.4161/cc.8.17.9457
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Despite the constant exposure to genomic insults that may lead to malignancy, cancer is surprisingly a relatively rare occurrence, and this is largely credited to an elaborate network of endogenous tumor suppression. Many effectors of tumor suppression have been identified, and their functions when activated in damaged cells have in large part been elucidated. What is less clear is whether there are common target gene(s) of tumor suppression, whose expression must be ablated in order to block transformation and preserve cellular homeostasis. Fresh experimental evidence suggests that silencing of the mitotic regulator and cell death inhibitor, survivin, is a universal requirement for successful tumor suppression in humans.
引用
收藏
页码:2708 / 2710
页数:3
相关论文
共 27 条
[1]   FoxOs at the crossroads of cellular metabolism, differentiation, and transformation [J].
Accili, D ;
Arden, KC .
CELL, 2004, 117 (04) :421-426
[2]   Opinion - Survivin, cancer networks and pathway-directed drug discovery [J].
Altieri, Dario C. .
NATURE REVIEWS CANCER, 2008, 8 (01) :61-70
[3]   Colonic crypt changes during adenoma development in familial adenomatous polyposis - Immunohistochemical evidence for expansion of the crypt base cell population [J].
Boman, BM ;
Walters, R ;
Fields, JZ ;
Kovatich, AJ ;
Zhang, T ;
Isenberg, GA ;
Goldstein, SD ;
Palazzo, JP .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (05) :1489-1498
[4]   Cancer-specific activation of the survivin promoter and its potential use in gene therapy [J].
Chen, JS ;
Liu, JC ;
Shen, L ;
Rau, KM ;
Kuo, HP ;
Li, YM ;
Shi, D ;
Lee, YC ;
Chang, KJ ;
Hung, MC .
CANCER GENE THERAPY, 2004, 11 (11) :740-747
[5]   Growth factor-dependent regulation of survivin by c-myc in human breast cancer [J].
Cosgrave, Niarnh ;
Hill, Arnold D. K. ;
Young, Leonie S. .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2006, 37 (03) :377-390
[6]   Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1) [J].
Daly, C ;
Wong, VV ;
Burova, E ;
Wei, Y ;
Zabski, S ;
Griffiths, J ;
Lai, KM ;
Lin, HC ;
Ioffe, E ;
Yancopoulos, GD ;
Rudge, JS .
GENES & DEVELOPMENT, 2004, 18 (09) :1060-1071
[7]   Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma [J].
Grossman, D ;
McNiff, JM ;
Li, FZ ;
Altieri, DC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (06) :1076-1081
[8]   Endogenous Tumor Suppression Mediated by PTEN Involves Survivin Gene Silencing [J].
Guha, Minakshi ;
Plescia, Janet ;
Leav, Irwin ;
Li, Jing ;
Languino, Lucia R. ;
Altieri, Dario C. .
CANCER RESEARCH, 2009, 69 (12) :4954-4958
[9]   Transcriptional repression of the anti-apoptotic survivin gene by wild type p53 [J].
Hoffman, WH ;
Biade, S ;
Zilfou, JT ;
Chen, JD ;
Murphy, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (05) :3247-3257
[10]   Aberrant regulation of survivin by the RB/E2F family of proteins [J].
Jiang, YY ;
Saavedra, HI ;
Holloway, MP ;
Leone, G ;
Altura, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (39) :40511-40520